{"id":9451,"date":"2016-07-31T06:01:26","date_gmt":"2016-07-31T06:01:26","guid":{"rendered":"http:\/\/revoscience.com\/en\/?p=9451"},"modified":"2016-07-31T06:01:26","modified_gmt":"2016-07-31T06:01:26","slug":"singapore-scientists-grow-mini-human-brains","status":"publish","type":"post","link":"https:\/\/www.revoscience.com\/en\/singapore-scientists-grow-mini-human-brains\/","title":{"rendered":"Singapore scientists grow mini human brains"},"content":{"rendered":"<p style=\"text-align: justify;\"><span style=\"color: #000000;\"><em><strong style=\"color: #000000;\">Mini midbrains provide next generation platforms to investigate human brain biology, diseases and therapeutics.<\/strong><\/em><\/span><\/p>\n<figure id=\"attachment_9452\" aria-describedby=\"caption-attachment-9452\" style=\"width: 300px\" class=\"wp-caption alignright\"><a href=\"http:\/\/revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-9452\" src=\"http:\/\/revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg\" alt=\"A midbrain organoid in a petri dish. The black pigment is neuromelanin, a hallmark of the human midbrain. Source : A*STAR\" width=\"300\" height=\"221\" title=\"\"><\/a><figcaption id=\"caption-attachment-9452\" class=\"wp-caption-text\">A midbrain organoid in a petri dish. The black pigment is neuromelanin, a hallmark of the human midbrain.<br \/>Source : A*STAR<\/figcaption><\/figure>\n<p style=\"text-align: justify;\"><span style=\"font-weight: normal; color: #000000;\"><strong>SINGAPORE<\/strong> \u2013 Scientists in Singapore have made a big leap on research on the \u2018mini-brain\u2019. These advanced mini versions of the human midbrain will help researchers develop treatments and conduct other studies into Parkinson\u2019s Disease[1] (PD) and ageing-related brain diseases.<\/span><br style=\"font-weight: normal; color: #000000;\" \/><br style=\"font-weight: normal; color: #000000;\" \/><span style=\"font-weight: normal; color: #000000;\">These mini midbrain versions are three-dimensional miniature tissues that are grown in the laboratory and they have certain properties of specific parts of the human brains. This is the first time that the black pigment neuromelanin has been detected in an organoid model. The study also revealed functionally active dopaminergic neurons.<\/span><br style=\"font-weight: normal; color: #000000;\" \/><br style=\"font-weight: normal; color: #000000;\" \/><span style=\"font-weight: normal; color: #000000;\">The human midbrain, which is the information superhighway, controls auditory, eye movements, vision and body movements. It contains special dopaminergic neurons that produce dopamine \u2013 which carries out significant roles in executive functions, motor control, motivation, reinforcement, and reward. High levels of dopamine elevate motor activity and impulsive behaviour, whereas low levels of dopamine lead to slowed reactions and disorders like PD, which is characterised by stiffness and difficulties in initiating movements.<\/span><br style=\"font-weight: normal; color: #000000;\" \/><br style=\"font-weight: normal; color: #000000;\" \/><span style=\"font-weight: normal; color: #000000;\">Also causing PD is the dramatic reduction in neuromelanin production, leading to the degenerative condition of patients, which includes tremors and impaired motor skills. This creation is a key breakthrough for studies in PD, which affects an estimated seven to 10 million people worldwide. Furthermore, there are people who are affected by other causes of parkinsonism. Researchers now have access to the material that is affected in the disease itself, and different types of studies can be conducted in the laboratory instead of through simulations or on animals. Using stem cells, scientists have grown pieces of tissue, known as brain organoids, measuring about 2 to 3 mm long. These organoids contain the necessary hallmarks of the human midbrain, which are dopaminergic neurons and neuromelanin.<\/span><br style=\"font-weight: normal; color: #000000;\" \/><br style=\"font-weight: normal; color: #000000;\" \/><\/p>\n<p style=\"text-align: justify;\">[pullquote]Prof Tan Eng King, Research Director and Senior Consultant, Department of Neurology at NNI and Lead PI of the TCR Programme in PD, remarked, \u201cThe human brain is arguably the most complex organ and chronic brain diseases pose considerable challenges to doctors and patients.[\/pullquote]<\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: normal; color: #000000;\">Jointly led by Prof Ng Huck Hui from A*STAR\u2019s Genome Institute of Singapore (GIS) and Assistant Prof Shawn Je from Duke-NUS Medical School, this collaborative research between GIS, Duke-NUS, and the National Neuroscience Institute (NNI) is funded by the National Medical Research Council\u2019s Translational Clinical Research (TCR) Programme In Parkinson\u2019s disease (PD) and A*STAR. Other collaborators are from the Lieber Institute for Brain Development, the Johns Hopkins University School of Medicine, and the Nanyang Technological University.<\/span><br style=\"font-weight: normal; color: #000000;\" \/><br style=\"font-weight: normal; color: #000000;\" \/><span style=\"font-weight: normal; color: #000000;\">Assistant Prof Shawn Je from Duke-NUS Medical School\u2019s Neuroscience &amp; Behavioural Disorders Programme said, \u201cIt is remarkable that our midbrain organoids mimic human midbrain development. The cells divide, cluster together in layers, and become electrically and chemically active in three-dimensional environment like our brain. Now we can really test how these mini brains react to existing or newly developed drugs before treating patients, which will be a game changer for drug development.\u201d<\/span><br style=\"font-weight: normal; color: #000000;\" \/><br style=\"font-weight: normal; color: #000000;\" \/><span style=\"font-weight: normal; color: #000000;\">Prof Tan Eng King, Research Director and Senior Consultant, Department of Neurology at NNI and Lead PI of the TCR Programme in PD, remarked, \u201cThe human brain is arguably the most complex organ and chronic brain diseases pose considerable challenges to doctors and patients. This achievement by our Singapore team represents an initial but momentous scientific landmark as we continue to strive for better therapies for our patients.\u201d\u00a0<\/span><br style=\"font-weight: normal; color: #000000;\" \/><br style=\"font-weight: normal; color: #000000;\" \/><span style=\"font-weight: normal; color: #000000;\">GIS Executive Director Prof Ng Huck Hui said, \u201cConsidering one of the biggest challenges we face in PD research is the lack of accessibility to the human brains, we have achieved a significant step forward. The midbrain organoids display great potential in replacing animals\u2019 brains which are currently used in research; we can now use these midbrains in culture instead to advance our understanding and future studies for the disease, and perhaps even other related diseases.\u201d<\/span><br style=\"font-weight: normal; color: #000000;\" \/><br style=\"font-weight: normal; color: #000000;\" \/><span style=\"font-weight: normal; color: #000000;\">This research is supported by the National Research Foundation Singapore under its Translational and Clinical Research (TCR) Flagship Programme and administered by the Singapore Ministry of Health\u2019s National Medical Research Council.<\/span><br style=\"font-weight: normal; color: #000000;\" \/><br style=\"font-weight: normal; color: #000000;\" \/><span style=\"font-weight: normal; color: #000000;\">Parkinson&#8217;s disease is a gradually progressive neuro-degenerative disorder which affects movement or the control of movement, including speech and body language. It affects about three in every 1,000 Singaporeans aged 50 years and above.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scientists in Singapore have made a big leap on research on the \u2018mini-brain\u2019. These advanced mini versions of the human midbrain will help researchers develop treatments and conduct other studies into Parkinson\u2019s Disease[1] (PD) and ageing-related brain diseases.<\/p>\n","protected":false},"author":6,"featured_media":9452,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,17],"tags":[],"class_list":["post-9451","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biology","category-research"],"featured_image_urls":{"full":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"thumbnail":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783-150x150.jpg",150,150,true],"medium":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"medium_large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"1536x1536":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"2048x2048":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"ultp_layout_landscape_large":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"ultp_layout_landscape":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"ultp_layout_portrait":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"ultp_layout_square":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"newspaper-x-single-post":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"newspaper-x-recent-post-big":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"newspaper-x-recent-post-list-image":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",88,65,false],"web-stories-poster-portrait":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",300,221,false],"web-stories-publisher-logo":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",96,71,false],"web-stories-thumbnail":["https:\/\/www.revoscience.com\/en\/wp-content\/uploads\/2016\/07\/3783.jpg",150,111,false]},"author_info":{"info":["Amrita Tuladhar"]},"category_info":"<a href=\"https:\/\/www.revoscience.com\/en\/category\/news\/biology\/\" rel=\"category tag\">Biology<\/a> <a href=\"https:\/\/www.revoscience.com\/en\/category\/news\/research\/\" rel=\"category tag\">Research<\/a>","tag_info":"Research","comment_count":"0","_links":{"self":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts\/9451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/comments?post=9451"}],"version-history":[{"count":0,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/posts\/9451\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/media\/9452"}],"wp:attachment":[{"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/media?parent=9451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/categories?post=9451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.revoscience.com\/en\/wp-json\/wp\/v2\/tags?post=9451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}